Semler Scientific Doubles Down on Bitcoin While Wall Street Skeptics Miss the Boat
Bitcoin's latest corporate convert isn't waiting for permission.
Semler Scientific just made a nine-figure bet on Bitcoin - while traditional finance still debates whether crypto belongs in portfolios. The medical tech firm's aggressive move comes as institutional adoption hits record highs, leaving skeptics scrambling to explain why they're still stuck on 'volatility' concerns.
Wall Street's loss? A 200% institutional adoption surge since 2023. Maybe ask your financial advisor why their 'prudent' strategy still involves 19th-century asset classes.
Coinbase Picks Luxembourg for Its New EU Headquarters, Secures MiCA License
In his view, market hesitation is often the breeding ground for the highest returns. He described his approach as deliberately contrarian, saying some of his most successful investments were made when he was virtually alone in his conviction. He believes Bitcoin now fits that mold perfectly.
Semler’s aggressive posture also aligns with broader trends. According to a 2024 report by PwC and the Alternative Investment Management Association, nearly half of hedge fund managers now hold some exposure to crypto—up from 29% in 2023. Meanwhile, a 2021 Intertrust Global survey found that 98% of CFOs at major hedge funds expected to allocate around 7.2% of assets to digital currencies by 2026.
While Wall Street waits on clarity, Semler is acting—and betting that time will prove him right.
